Recent

% | $
Quotes you view appear here for quick access.

Nokia Corporation Message Board

blimpsrus2001 127 posts  |  Last Activity: May 4, 2016 8:19 AM Member since: Jan 22, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    MELISSA GOT THE MAKE UP CAKED ON

    by daytradegenius May 4, 2016 7:54 AM
    blimpsrus2001 blimpsrus2001 May 4, 2016 8:19 AM Flag

    She has a weight problem she cannot wait to eat.She is on a seafood diet she sees food she eats it

  • Fitbit (NYSE:FIT) – Research analysts at SunTrust lifted their FY2016 earnings per share estimates for shares of Fitbit in a report issued on Friday, according to Zacks Investment Research. SunTrust analyst R. Peck now forecasts that the firm will earn $0.89 per share for the year, up from their previous estimate of $0.88. SunTrust currently has a “Buy” rating on the stock. The consensus estimate for Fitbit’s FY2016 earnings is $0.89 per share.

    A number of other equities analysts have also commented on FIT. Barclays cut their price objective on Fitbit from $49.00 to $24.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 24th. Dougherty & Co reaffirmed a “neutral” rating on shares of Fitbit in a research note on Tuesday, March 8th. Mizuho reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Fitbit in a research note on Thursday, March 31st. Longbow Research reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Fitbit in a research note on Saturday, April 16th. Finally, Piper Jaffray reaffirmed an “overweight” rating and issued a $60.00 price objective on shares of Fitbit in a research note on Friday, February 5th. Thirteen equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. Fitbit presently has a consensus rating of “Buy” and an average target price of $31.14.Fitbit (NYSE:FIT) opened at 18.25 on Monday. Fitbit has a 52 week low of $11.91 and a 52 week high of $51.90. The company’s 50 day moving average is $15.67 and its 200 day moving average is $22.74. The stock has a market cap of $3.84 billion and a P/E ratio of 24.40.


    Fitbit (NYSE:FIT) last announced its quarterly earnings data on Monday, February 22nd. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.10. The firm had revenue of $711.60 million for the quarter, compared to analysts’ expectations of $647.94 million. Fitbit’s revenue for the quarter was up 92.2% compared to the same quarter last year.In other news, major shareholder Group Select Fund L.P Foundry sold 1,111,850 shares of the company’s stock in a transaction on Thursday, February 11th. The stock was sold at an average price of $13.46, for a total transaction of $14,965,501.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Hansgregory C. Hartmann sold 150,000 shares of the company’s stock in a transaction on Monday, April 18th. The shares were sold at an average price of $17.19, for a total value of $2,578,500.00. Following the transaction, the chief operating officer now directly owns 150,000 shares in the company, valued at approximately $2,578,500. The disclosure for this sale can be found here.

    Several hedge funds and institutional investors have recently modified their holdings of FIT. Franklin Street Advisors boosted its position in shares of Fitbit by 1,380.6% in the fourth quarter. Franklin Street Advisors now owns 96,240 shares of the company’s stock worth $2,848,000 after buying an additional 89,740 shares in the last quarter. Emerald Advisers Inc. PA boosted its position in shares of Fitbit by 65.6% in the fourth quarter. Emerald Advisers Inc. PA now owns 124,721 shares of the company’s stock worth $3,690,000 after buying an additional 49,405 shares in the last quarter. Simplex Trading boosted its position in shares of Fitbit by 43.6% in the fourth quarter. Simplex Trading now owns 3,017 shares of the company’s stock worth $1,453,000 after buying an additional 916 shares in the last quarter. Eagle Asset Management purchased a new position in shares of Fitbit during the third quarter worth approximately $42,894,000. Finally, Hamilton Lane Advisors LLC purchased a new position in shares of Fitbit during the fourth quarter worth approximately $6,743,000.

    Fitbit, Inc (NYSE:FIT) is a provider of health and fitness products. The Company’s Fitbit platform combines connected health and fitness devices with software and services, including an online dashboard and mobile applications, data analytics, motivational and social tools, personalized insights, and virtual coaching through fitness plans and interactive workouts.

  • As the fitness tracker moves into medical gadgets, it risks flagging the attention of the FDA

    The line between health tracker and medical device is blurring, and as Fitbit plans to move further into the clinical technology marketplace it risks flagging the attention of the FDA, according to Bloomberg.

    Last year, the Food and Drug Administration (FDA) released draft guidance making clear its intention to closely scrutinize certain sectors of the mHealth wearable market. However, as Health IT Outcomes reported, low-risk wearables, apps, and mHealth devices intended to support general wellness or healthy lifestyle choices will not be included in that scrutiny.

    The guidance targeted those apps and devices which track user input and make health claims about the wearable’s ability to provide encouragement or help manage conditions or health attributes without intending to treat or influence a patient’s safety and care.

    “General wellness products can include exercise equipment, audio recordings, mobile apps, video games, and other products that are typically available from retail establishments (including online retailers and distributors that offer mobile apps to be directly downloaded),” when the items in question present an insignificant risk to a patient’s safety, FDA officials says.

    That original guidance did not include low-risk devices, like the Fitbit, however.

    But as Fitbit strives to reinvent itself as a “digital health company,” introducing a heart-monitoring bracelet last year and planning a range of clinical technology products for the healthcare industry in the near future, it may be garnering closer attention from the FDA.As Bloomberg explained, this is a difficult transition since tracking a person’s vital signs is much more complicated than counting a runner’s paces. In fact, a class-action suit has by filed by consumers in several states claiming the heart-monitoring technology in the Fitbit is “wildly inaccurate,” undercounting heart rates by as much as 75 beats per minute. The suit alleges that this could cause physical harm to users.

    Closer regulation from the FDA would present a challenge to Fitbit’s expansion. Charlie Anderson, analyst with Dougherty & Company, told Bloomberg, “It will make things trickier from a timing perspective. If you don’t have to go to the FDA, you can release products when you want to. If you go to the FDA, it depends on when they can approve things.”

    Fitbit is currently used by two of the largest U.S. health insurers in diabetes and weight-management programs, and it includes a corporate wellness program to encourage healthier lifestyles through the use of company-issued Fitbits. In the future, Fitbit gadgets could potentially be used to monitor blood pressure, measure glucose levels, and even diagnose disease.

    “We’re not there yet,” Chief Executive Officer James Park told Bloomberg, “But we think five to 10 years down the line, the power of these devices to help consumers, healthcare providers, the whole healthcare ecosystem track and give diagnoses to people — I think it’s incredibly tantalizing.”

  • As my followers know, I have been bearish on Fitbit (NYSE:FIT) for quite some time now.

    I have recommended shorting the stock multiple times in the past, and the stock is down almost 40% since my initial short call. While I am still bearish on Fitbit in the long term, investors should close their short positions going into earnings and take their profits off the table.

    Earnings expectations

    Fitbit is expected to release its quarterly report on May 4. Analysts are expecting Fitbit to post earnings of 2 cents per share while its revenue is expected to come in at approximately $440 million. Fitbit’s business has no moat and is prone to strong competition. However, after Apple’s (NASDAQ:AAPL) weak earnings, investors should be cautious and close their short positions.As most people probably know, Apple shared terrible quarterly results earlier this week. Not only did the sales of the iPhone 6S decline, other products like the Apple Watch and the iPad also witnessed severe decline and underwhelmed.

    Apple’s loss may lead to Fitbit’s gain. Fitbit may have been able to gain on Apple by undercutting it on price, and I will not be surprised if Fitbit delivers better-than-expected earnings. That being said, I am not 100% certain Fitbit will beat on earnings; investors should take their profits off the table.

    Moreover, shorting Fitbit is expensive due to its massive short float. Hence, heading into earnings, shorting Fitbit is not worth the risk as the high borrowing rates along with a potential short squeeze can lead to massive losses.

    However, Apple is not the only competition that Fitbit faces. The likes of Xiaomi and Garmin (NASDAQ:GRMN) can still snatch Fitbit’s market share, which is why I am bearish on the stock in the long run.Conclusion

    While I still expect Fitbit to fall to just a little over $10 in the long run, Fitbit is a risky short heading into earnings. Investors should cover their short positions and book profits as Apple’s weak Watch sales may lead to better-than-expected Fitbit sales, which in turn can cause a massive short squeeze.

    Hence, investors should cover their short positions and wait for better opportunities to short Fitbit from the sidelines. Investors with an appetite for risk can also consider initiating a short-term long position in the stock before the earnings date.

    Disclosure: The author doesn’t have any position in the stock mentioned in the article.

  • CEO Mark Zuckerberg sure knows how to please FB stock owners. The formula is pretty simple, really: Just string together a series of blowout quarters and make your competitors look awful by comparison. James Park identical formula

  • Apple is "outdated" and losing momentum in China, billionaire entrepreneur Jia Yueting told CNBC in his first international television interview.

    Jia is chief executive and chairman of Chinese conglomerate LeEco (formerly LeTV), which is best known for being the "Netflix of China," but has a product range that includes smartphones, televisions, mountain bikes and, most recently, electric vehicles.

    Last week LeEco launched the self-driving, smart LeSEE supercar, designed to rival Tesla's Model X. In the latest evolution of the "LeEco ecosystem," Jia hopes to sell content, including movies, TV shows and music to LeSEE drivers.China.
    Speaking at a meeting of the China Entrepreneur Club, an exclusive summit of business leaders, 43-year old Jia explained why foreign rivals did not worry him, particularly Apple, which is also expanding its ecosystem beyond consumer technology to driverless cars.

    "We think the difference between us and Apple is very large. Apple is a mobile phone company focused on hardware and software," Jia said at the weekend event in Jinan. "LeShi [another name for LeEco] is focused on the internet first, and only then on software, and finally on hardware."

    Apple's product design was also obsolete, he added.

    "Apple only has individual apps. This was the right choice during the first generation of mobile net, when CPUs [central processing units] and the mobile network speeds were not fast enough," Jia said. "However now we're moving into the next era of mobile internet, these problems no longer exist. Moreover, having separate apps just means great obstacles in the user experience. We hope to break down these obstacles."Sales in China, Apple's second-biggest market, have also deteriorated, Jia noted.

    "One of the most important reasons [for slowing sales] is that Apple's innovation has become extremely slow," he said. "For example, a month ago Apple launched the iPhone SE. From an industry insider's perspective, this is a product with a very low level of technology...We think this is something they just shouldn't have done."

    Apple's SE phone could increase the company's installed customer base for other services over the long term, said Angelo Zino senior industry analyst at S&P Global Market Intelligence. But there's a possibility that the lower-priced iPhone SE could pressure Apple's margins, if its effort to attract customers in emerging markets means fewer sales of high-end products, Abhey Lamba, senior technology analyst at Mizuho Securities, told CNBC's "Power Lunch" Monday.

    "When we look at Apple they clearly need the next ... driver," Lamba said. "The Watch hasn't cut it. And they're looking at content on the services side, on the iTunes side. We'll see how that works out. But definitely they need something to drive the next leg of growth."
    Apple is "outdated" and losing momentum in China, billionaire entrepreneur Jia Yueting told CNBC in his first international television interview.

    Jia is chief executive and chairman of Chinese conglomerate LeEco (formerly LeTV), which is best known for being the "Netflix of China," but has a product range that includes smartphones, televisions, mountain bikes and, most recently, electric vehicles.

    Last week LeEco launched the self-driving, smart LeSEE supercar, designed to rival Tesla's Model X. In the latest evolution of the "LeEco ecosystem," Jia hopes to sell content, including movies, TV shows and music to LeSEE drivers.

    Jia Yueting introduces the all-electric battery 'concept' car LeSEE on April 20, 2016 in Beijing, China.
    VCG/VCG | Getty Images
    Jia Yueting introduces the all-electric battery 'concept' car LeSEE on April 20, 2016 in Beijing, China.
    Speaking at a meeting of the China Entrepreneur Club, an exclusive summit of business leaders, 43-year old Jia explained why foreign rivals did not worry him, particularly Apple, which is also expanding its ecosystem beyond consumer technology to driverless cars.

    "We think the difference between us and Apple is very large. Apple is a mobile phone company focused on hardware and software," Jia said at the weekend event in Jinan. "LeShi [another name for LeEco] is focused on the internet first, and only then on software, and finally on hardware."

    Apple's product design was also obsolete, he added.

    "Apple only has individual apps. This was the right choice during the first generation of mobile net, when CPUs [central processing units] and the mobile network speeds were not fast enough," Jia said. "However now we're moving into the next era of mobile internet, these problems no longer exist. Moreover, having separate apps just means great obstacles in the user experience. We hope to break down these obstacles."

    A Chinese policeman stands guard in front of a portrait of Mao Zedong at Tiananmen Square in Beijing, China.
    China could slam door on Apple—top risk expert explains why
    Sales in China, Apple's second-biggest market, have also deteriorated, Jia noted.

    "One of the most important reasons [for slowing sales] is that Apple's innovation has become extremely slow," he said. "For example, a month ago Apple launched the iPhone SE. From an industry insider's perspective, this is a product with a very low level of technology...We think this is something they just shouldn't have done."

    Apple's SE phone could increase the company's installed customer base for other services over the long term, said Angelo Zino senior industry analyst at S&P Global Market Intelligence. But there's a possibility that the lower-priced iPhone SE could pressure Apple's margins, if its effort to attract customers in emerging markets means fewer sales of high-end products, Abhey Lamba, senior technology analyst at Mizuho Securities, told CNBC's "Power Lunch" Monday.

    "When we look at Apple they clearly need the next ... driver," Lamba said. "The Watch hasn't cut it. And they're looking at content on the services side, on the iTunes side. We'll see how that works out. But definitely they need something to drive the next leg of growth."
    Charles Chao, chief executive officer of Sina Corp., attends an IPO ceremony for Weibo Corp.
    Sina CEO Chao: Weibo's not for sale ... right now
    As an industry leader, Apple should be developing more cutting-edge products, Jia said. The iPhone was still a leader five years ago after being launched in 2008 but now the concept has "fallen behind," he said. Apple did not immediately respond to CNBC's request for comment.
    "We believe the next generation of mobile internet will be more open, more ecosystem oriented instead of being a closed loop...Ironically, Apple's over-dominance, lack of internet-thinking and the closed off nature of its systems, all hindered innovation in the internet mobile industry," Jia said.

    The Cupertino giant is expected to report a fall in smartphone sales when it announces first-quarter earnings on Tuesday.

    "At this point we think Apple has now turned into this great valuation play, whereas if we do see some momentum on the iPhone 7 side, I think, all of a sudden, you start baking in some sort of growth driver for the company," Zino told "Power Lunch."
    It noted "some signs of economic softness" in the Greater China region, particularly Hong Kong, when announcing fourth-quarter results in late January. But chief executive Tim Cook said the company remained "very bullish on China" given the low penetration of high-speed mobile data usage and the growing middle class.Jia, who started as a tech support worker before building his own IT and mobile company into a fortune estimated to be around $4.8 billion, is not shy when it comes to taking on industry leaders.

    At the LeSee's launch, he told Reuters that while Tesla was a "great company," he was not "just building a car."

    "We consider the car a smart mobile device on four wheels, essentially no different to a cellphone or tablet," he said. "We hope to surpass Tesla and lead the industry leapfrogging to a new age."

    The LeSEE will be on display at the Beijing Auto Show this week.

  • CEO of a company in China equivalent to Amazon said Apple outdated all about content now.Well have to admit though Apple did one heck of job raping the public with their low quality products the last 13 yrs.

  • blimpsrus2001 blimpsrus2001 Apr 18, 2016 10:52 AM Flag

    Sounds more like chronic bow movement :)

  • Fitbit's Move Into Medical Gadgets Risks Attracting FDA Scrutiny
    Selina WangApr 15, 2016 10:27 am ET
    (Bloomberg) -- Fitbit Inc. won over Wall Street with a series of hit fitness trackers. Now, with competition intensifying and new products selling less briskly than expected, investors are clamoring for a next act.

    Fitbit’s answer is turn itself into a “digital health company” that relies less on consumers. Having introduced a heart-monitoring bracelet last year, the company eventually wants to sell a range of clinical technology to the health-care industry.

    The strategy has merit since it would dramatically broaden Fitbit’s market beyond fitness enthusiasts. But counting a runner’s paces is relatively simple: tracking someone’s vital signs is far more fraught. Exhibit A: a class-action lawsuit filed by consumers in several states alleging that Fitbit’s heart-monitoring technology is “wildly inaccurate” and could cause harm because it under-counts heart rates by as much as 75 beats per minute. As Fitbit pushes further into medical technology, it could attract the attention of the U.S. Food and Drug Administration, which regulates medical devices.

    That would complicate the business, said Charlie Anderson, a Dougherty & Company analyst. “It will make things trickier from a timing perspective,” he said. “If you don’t have to go to the FDA you can release products when you want to. If you go to the FDA it depends on when they can approve things.”

    Chief Executive Officer James Park is determined to remain a leading player amid competition from Apple on the high end, China’s Xiaomi Corp. on the low end and multiple players in between. He sees clinical technology as a natural next step for nine-year-old Fitbit. The company has more than quintupled its annual research and development budget in the last three years to $150 million and has hired scores of software developers and hardware engineers -- “mad scientists,” investor-relations chief Brad Samson jokingly calls them.

    Fitbit devices are already used in diabetes and weight-management programs for two of the largest U.S. health insurers. Its corporate wellness program, where companies give employees Fitbit activity trackers to encourage healthier lifestyles, generates less than 10 percent of revenue for now but is growing in size. Park, who declined to discuss specific products, said Fitbit is working on more advanced sensors and moving in a more clinical and medical-grade direction. Ultimately, Fitbit gadgets could monitor blood pressure, blood sugar and even diagnose disease.

    “We’re not there yet,” Park, 39, said in an interview. “But we think five to 10 years down the line, the power of these devices to help consumers, health-care providers, the whole health-care ecosystem track and give diagnoses to people -- I think it’s incredibly tantalizing.”

    Park said Fitbit is on the lookout for digital health companies to acquire . “M&A is definitely an important part of out strategy,” he said.

    Analysts say that while the health-care push makes sense in the long-term, it will take time to get there, meaning profits will take a hit as the company ramps up R&D and fends off competition in the consumer wearables market.

    “The health-care market is still early-stage and is going to be more expensive to develop for than the consumer market,” said Steven Wardell , an analyst at Leerink Partners. “If they choose to make clinical claims and seek FDA approval, then they’ll probably find that it will cost more and take longer.”

    That emerging reality has put pressure on the shares, which have fallen more than 40 percent this year. And the heart-monitor lawsuit isn’t exactly easing investors’ concerns.

    The plaintiffs allege that Fitbit’s advertising -- with slogans like “Every beat counts” and pictures of users doing strenuous activity accompanied by images of charts delivering real-time elevated heart readings -– made consumers believe that they could rely on the accuracy of the product.

    Plaintiff David Urban bought a Fitbit PurePulse Tracker to monitor his heart rate while training for a marathon. Because Urban has a family history of heart disease, his doctor recommended that he keep his heart rate from exceeding 160 beats per minute. Urban alleges the tracker consistently under-recorded his pulse by as much as 25 bpm. Dr. Vincent Pedre, who practices internal medicine, says if users with cardiovascular diseases rely on a device that under-reports their heart rates, then the user could exercise at a level that puts stress on the organ, potentially leading to a heart attack.

    Asked about the case, Fitbit CEO Park said: “People need to use common sense. It’s not a medical-grade device; it’s a consumer device. In that setting, it works incredibly well. You should probably follow your doctor’s advice and use whatever device they prescribe to you. Just use your judgment.”

    Fitbit says the suit has no merit and plans to contest it vigorously.

    So far the FDA has opted not to regulate what it calls “general wellness devices.” But in an interview Bakul Patel, the agency’s associate director for digital health, said the FDA would start regulating the technology if and when Fitbit claims to diagnose and treat specific conditions.

    Park professes little concern. “I think we’ve had a pretty open policy with regulators,” he said. “I’ve been out to DC multiple times already. We want to work together with the government to find the right balance.”

  • With the Fitbit platform James is creating future revenue will be astronomical to Facebook.James knows what he needs to do and will execute it.Will take time but when the time comes this stock will soar.

    Sentiment: Strong Buy

  • blimpsrus2001 blimpsrus2001 Apr 6, 2016 10:13 AM Flag

    Everyone I have talked to owns an iphone and they said same thing.I am hearing it from the Apple lovers or Apple cult.Because the price is higher than any other phone does not make it a quality phone.Apple was very smart how they sol the product.Pump out a limited amount and people beg for more.I do believe Apple lovers do not want to hear this is because they got sucked into buying this #$%$ and feel like idiots for going for the bait.

  • blimpsrus2001 blimpsrus2001 Apr 6, 2016 9:05 AM Flag

    What amazes me is how Apple sold over a billion phones and got the out rages price that they did on the iphone. Low quality phone at that.I had a chance to buy Apple stock 1998 but at the time new nothing about stocks technology or Steve Jobs for that matter..3,000 investment then would be around a million today. Fitbits may be made like junk but they are not charging 600.00 like the iphone cost.People are morons it is amazing. But if you look at it that way you will make money off of the ignorant people.This is why Fitbit will do so well.

    Sentiment: Strong Buy

  • blimpsrus2001 blimpsrus2001 Apr 6, 2016 8:47 AM Flag

    I purchased the Blaze for my friends son he is 17. He mentioned that he did not see anyone else wearing the Blaze in his school.One of his friends said that he will get rid of the Apple watch and purchase the Blaze.I told him to show the Blaze and explain how it works and he said that the kids are going to get the Blaze.Grfeat salesman he is.The kids love them wow look out Apple here we come

  • Fitness trackers are a long way off replacing our doctors, but as a new case has shown, tracking heart rate information can alert users to some health problems when they arise.

    In a recent case an emergency physicians used the heart rate information from a Fitbit to work out when a patient's irregular heart rate began.

    From there the medical experts were able to identify the problem, be certain they could treat him with a defibrillator, and discharge him home. Without that information to hand, it would have taken them much longer to do.

    Helping band

    The patient had no previous history of cardiac disease or history of seizures, but the Fitbit app showed that his heart beat was between 130 to 190 beats per minute.

    Alfred Sacchetti, author of the study, said: "Using the patient's activity tracker - in this case, a Fitbit - we were able to pinpoint exactly when the patient's normal heart rate of 70 jumped up to 190."

    "The device told us that the patient's atrial fibrillation was present for only a few hours. That was well within the 48-hour window needed to consider him for rhythm conversion, so we cardioverted him and sent him home."

    The study didn't make it clear which Fitbit product was used to identify the problem.

    Bringing fitness tracking tech into the medical industry may bring extra benefits, but a large concern is the accuracy of the heart rate tracking tech on popular fitness bands.

    Reports of inaccurate readings from Fitbit products have even meant the company has even been sued by customers for putting their health in danger. What happens if your fitness tracker emits the wrong reading and a medical professional uses it to treat you?

    The best fitness trackers for 2016

    Sentiment: Strong Buy

  • Reply to

    IF you believe in FIT, buy and hold...

    by brianhong1 Apr 4, 2016 10:45 AM
    blimpsrus2001 blimpsrus2001 Apr 4, 2016 10:56 AM Flag

    I have no choice down a lot but from what I have read about James Park no worries here.He is a lot smarter than Tim Cook and Mark zuckerburg.James going after Apple I see this coming. Fitbit A 100.00 stock just be patient

  • Fitbit Inc (NYSE:FIT) shares are surging today after Longbow Research initiated bullish coverage on the stock. Longbow analyst, Joe Wittine, said that the Fitbit’s new products, Blaze and Alta, are off to a great start. Based on his discussions with retailers, he said that Blaze has seen very strong initial uptake with consumers.

    On Alta, Mr. Wittine’s analysis shows that one-third of initial purchases of the device were from existing Fitbit owners, and many of them were an upgrade from lower-priced products of the company like Charge and Flex. He believes that this would help in increasing average selling prices.

    The analyst said that consumer interest is such that Fitbit will again be the gift of choice on Mother’s Day and Father’s Day this year. He thinks that positive response to new products will help in boosting stock price in the near term.

    Corporate wellness sales represent a long term opportunity for Fitbit, Mr. Wittine is of the opinion. “Corporate wellness represents just ~10% of [Fitbit’s] sales today, but could scale materially as [Fitbit] is just now honing its marketing message,” he said.
    The analyst points out that Fitbit has only two major competitors, Apple Watch and Xiaomi. He says that Apple is the biggest long term threat, but it does not seem to launch a pure fitness tracking device at this point in time. Xiaomi won’t be able to overwhelm Fitbit’s perceived quality and brand image in mature markets, the analyst said.

    As far as other players like Jawbone and Garmin are concerned, Mr. Wittine believes they will fail to compete effectively against Fitbit’s technological updates and brand recognition. Fitbit retains a dominant position in the wearable market followed by Apple Watch, according to IDC. The company’s success has come on the back of broadening product portfolio and international expansion. More products like Blaze and Alta will set the stage for upbeat gains.

  • blimpsrus2001 by blimpsrus2001 Feb 20, 2016 9:53 AM Flag

    Why Fitbit is shifting focus from fitness to fashion However, Sheehan has a bold message for critics. Having spent more than seven years as European marketing manager at Kodak, she watched the company’s mainstream status disappear almost over night. The Fitbit brand, she insists, is here to stay and will not be having any Kodak moments.

    “The biggest issue at Kodak was that we failed to innovate. The company failed to recognise there were plenty of smaller brands out there that could create more inspiring and connected ideas.

    “At Fitbit, it’s a different story. We are a leaner company with only 1,000 employees across the globe. The culture is heavily driven by innovation and the ability to voice and develop ideas.”

    This innovation could also see Fitbit extend beyond the wearables market. Sheehan concludes: “We are focused on delivering the best technology but only on devices that people want to use. There’s endless long-term potential, for example, in how virtual reality can change the fitness category. Fitbit is just scratching the surface in bringing technology to the fitness sector.”

  • blimpsrus2001 blimpsrus2001 Feb 9, 2016 6:26 AM Flag

    Do not look at it if you are only down 6k you are fortunate a lot of investors down a lot more than that and I am one of them.

  • blimpsrus2001 blimpsrus2001 Jan 14, 2016 8:10 AM Flag

    Dumbed down society unreal I feel sorry for you GL in future you will need it.The Dumbing Down of America – By Design a good book for you to read unless you do not know how to read/understand what you are reading.

  • blimpsrus2001 blimpsrus2001 Jan 14, 2016 7:59 AM Flag

    It figures Huawei no different.than Apple.I bet you have a Facebook acct?

NOK
5.600.000(0.00%)May 27 4:03 PMEDT